0001477932-23-001048.txt : 20230215 0001477932-23-001048.hdr.sgml : 20230215 20230215064931 ACCESSION NUMBER: 0001477932-23-001048 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20230214 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230215 DATE AS OF CHANGE: 20230215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UPEXI, INC. CENTRAL INDEX KEY: 0001775194 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 833378978 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40535 FILM NUMBER: 23633572 BUSINESS ADDRESS: STREET 1: 17129 US HWY 19 N. CITY: CLEARWATER STATE: FL ZIP: 33760 BUSINESS PHONE: 701-353-5425 MAIL ADDRESS: STREET 1: 17129 US HWY 19 N. CITY: CLEARWATER STATE: FL ZIP: 33760 FORMER COMPANY: FORMER CONFORMED NAME: GROVE, INC. DATE OF NAME CHANGE: 20190429 8-K 1 upxi_8k.htm FORM 8-K upxi_8k.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

 

FORM 8-K

_________________

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): February 14, 2023

_______________________________

 

UPEXI, INC.

(Exact name of registrant as specified in its charter)

_______________________________

 

Nevada

 

333-25526

 

83-3378978

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

17129 US Hwy 19 N.

Clearwater, FL 33760

(Address of Principal Executive Offices) (Zip Code)

 

(701) 353-5425

(Registrant's telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

_______________________________

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common Stock, par value $0.001

 

UPXI

 

NASDAQ

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Section 2 – Financial Information

 

Item 2.02 Results of Operations and Financial Condition.

 

On February 14, 2023, Upexi, Inc. (the “Company”) issued a press release announcing financial and operational results and business highlights for the three and six months ended December 31, 2022 (the “Press Release”). A copy of the Press Release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

In accordance with General Instruction B.2 of Form 8-K, the information in this Form 8-K (including Exhibit 99.1) is being “furnished,” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section nor shall they be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

Section 9 – Financial Statements and Exhibits

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit No.

Exhibit Description

99.1

Press Release of Upexi, Inc., dated February 14, 2023

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL Document).

 

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

UPEXI, INC.

 

 

 

 

Dated: February 15, 2023

/s/ Andrew J. Norstrud

 

 

Name: Andrew J. Norstrud

 

 

Title: Chief Financial Officer

 

 

 

3

 

 EX-99.1 2 upxi_ex991.htm PRESS RELEASE upxi_ex991.htm

EXHIBIT 99.1

 

Upexi Reports Record Revenue of $27.1 Million for Fiscal 2023

Second Quarter, an Increase of 444% Year-Over-Year

 

HENDERSON, NV, February 14, 2023 (GLOBE NEWSWIRE) – Upexi, Inc. (NASDAQ: UPXI) (the “Company” or “Upexi”), a multi-faceted Amazon and Direct to Consumer brand owner and innovator in aggregation, today announced its financial results for the fiscal 2023 second quarter ending December 31, 2022.

 

Fiscal 2023 Second Quarter Financial Highlights:

 

 

·

 Revenue totaled $27.1 million, an increase of 444% year-over-year, and an increase of 134% sequentially.

 

·

 Gross profit totaled $10.3 million, an increase of $6 million or an increase of 141% year-over-year and an increase of 71% sequentially.

 

·

 Adjusted EBITDA for the quarter totaled $119,054 as compared to an adjusted EBITDA loss of $1.3 million year over year, and an improvement of $1.1 million over the prior quarter.

 

·

 Net Income from continued operations attributable to Upexi, Inc. shareholders was $2.7 million, as compared to a net loss of approximately $258,247 for the same period in the prior year. This includes a one-time gain of $7.6 million as a result of the sale of Infusionz and select assets.

 

·

 Shareholder equity increased $8.2 million to $36.9 million as of December 31, 2022, as compared to $28.7 million as of June 30, 2022.

 

·

 Cash and cash equivalents totaled $4.5 million as of December 31, 2022.

 

 

 

“The strategic measures we have taken during the last nine months have resulted in record revenue and positive Adjusted EBITDA for our fiscal 2023 second quarter,” stated Allan Marshall, Upexi Chief Executive Officer. “During that period we divested our select CBD operations and focused our resources on our diverse business mix of non-discretionary brands in health, wellness, pet, toys, and liquidation in wholesale, DTC and Amazon.”

 

Mr. Marshall continued, “During the quarter we transitioned sequentially from an Adjusted EBITDA loss to positive Adjusted EBITDA. Throughout the remainder of calendar 2023 we expect to see further efficiency in our operations, which will drive higher EBITDA margins. The business is well positioned to meet our projected revenue goal of $100 million for calendar 2023 and we expect EBITDA margins to increase steadily throughout the calendar year to trend towards 8% to 12% by end of year.”

 

 

 

 

Fiscal 2023 Second Quarter and Subsequent Operational Highlights:

 

 

·

 Tytan Tiles launched branded Amazon storefront and into over 2,000 Walmart storefronts.

 

·

 Eliminated outstanding balance of $15 million senior secured debt.

 

·

 Closed acquisition of E-Core and subsidiaries, Tytan Products and New England Technology, Inc.

 

·

 Sold select CBD assets for $23.5 million.

 

·

 Filed new patent through the Company’s Ad Tech Division, Interactive Offers.

 

 

 

Financial Highlights for Fiscal 2023 Second Quarter

 

Revenue for the three months ended December 31, 2022 totaled $27.1 million, an increase of 444% as compared to $4.9 million for the same period the year prior. Revenue growth was predominantly driven by acquisitions as well as strong year-end sales in many of our brands including; E-core, Tytan Tiles, Vitamedica, and Cygnet Online, as well as strong sales from our pet product business, Lucky Tail.

 

Cost of revenue during the quarter totaled $16.8 million, compared to $.7 million for the same period the prior year. Gross profit for the quarter was $10.3 million, an increase of 141% as compared to $4.3 million for the same period in the prior year. Gross margins declined to 38%

 

Operating expenses totaled $12.5 million, an increase of 83% as compared to $6.8 million for the same period in the prior fiscal year.

 

The Company had a net loss from continued operations of $2.1 million for the three months ended December 31, 2022, representing a 16% improvement compared to the $2.5 million net loss for the same period the prior year.

 

The Company had cash of $4.5 million and stockholders' equity attributable to Upexi, In. stockholders of $36.9 million as of December 31, 2022. As of today, February 14, 2023, there are 17,960,748 shares of common stock outstanding.

 

Financial Results Conference Call

 

Event:

Fiscal 2023 Second Quarter Financial Results Conference Call

 

 

Date:

Tuesday, February 14, 2023

 

 

Time:

5:00 p.m. Eastern Time

 

 

Live Call:

1-877-407-9716 (U.S. Toll-Free) or 1-201-493-6779 (International)

 

 

Webcast:

https://viavid.webcasts.com/starthere.jsp?ei=1596499&tp_key=f546e66677

 

For those unable to join the conference call, a dial-in replay of the call will be available until February 28, 2023 and can be accessed by dialing +1-844-512-2921 (U.S. Toll Free) or +1-412-317-6671 (International) and entering replay pin number: 13736086.

 

 
2

 

 

Additional details are available under the Investor Relations section of the Company’s website: https://upexi.com/investors.

 

About Upexi, Inc.:

Upexi is a multi-faceted brand owner with established brands in the health, wellness, pet, beauty and other growing markets. We operate in emerging industries with high growth trends and look to drive organic growth of our current brands. We focus on direct to consumer and Amazon brands that are scalable and have anticipated, high industry growth trends. Our goal is to continue to accumulate consumer data and build out a significant customer database across all industries we sell into. The growth of our current database has been key to the year over year gains in sales and profits. To drive additional growth, we have and will continue to acquire profitable Amazon and eCommerce businesses that can scale quickly and reduce costs through corporate synergies. We utilize our in-house, SaaS programmatic ad technology to help achieve a lower cost per acquisition and accumulate consumer data for increased cross-selling between our growing portfolio of brands.

 

FORWARD LOOKING STATEMENTS:

This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with business strategy, potential acquisitions, revenue guidance, product development, integration and synergies of acquiring companies and personnel. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

 

 
3

 

 

Use of Non-GAAP Financial Measures

 

The Company discloses and uses the above-mentioned non-GAAP financial measures internally as a supplement to GAAP financial information to evaluate its operating performance, for financial planning purposes, to establish operational goals, for compensation plans, to measure debt service capability, for capital expenditure planning and to determine working capital needs and believes that these are useful financial measures also used by investors. Non-GAAP adjusted EBITDA is defined as GAAP net income or net loss before interest, taxes, depreciation and amortization (EBITDA) adjusted for the non-cash stock compensation and stock option expense, acquisition, integration & restructuring expenses, charges and gains or losses from extinguishment of debt and other non-cash items. Non-GAAP EBITDA and non-GAAP adjusted EBITDA are not terms defined by GAAP and, as a result, the Company’s measure of non-GAAP EBITDA and non-GAAP adjusted EBITDA might not be comparable to similarly titled measures used by other companies. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance, financial position, or cash flow that either excludes or includes amounts that are not normally included in the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP financial measures discussed above, however, should be considered in addition to, and not as a substitute for, or superior to net income or net loss as reported for GAAP on the Consolidated Statements of Operations, cash and cash flows on the Consolidated Statement of Cash Flows or other measures of financial performance prepared in accordance with GAAP, and as reflected on the Company’s financial statements prepared in accordance with GAAP. These non-GAAP financial measures are not a substitute for or presented in lieu of financial measures provided by GAAP and all measures and disclosures of financial information pursuant to GAAP should be read to obtain a comprehensive and thorough understanding of the Company’s financial results. The reconciliations of non-GAAP EBITDA and non-GAAP adjusted EBITDA to GAAP operating income (loss) and/or GAAP net income (net loss) referred to in the highlights or elsewhere are provided in the schedules that are a part of this document.

 

Adjusted EBITDA

 

 

 

 

 

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

30-Sep-22

 

 

31-Dec-22

 

 

31-Dec-22

 

Net income (Net loss) GAAP

 

 

 (2,597,515 )

 

 

 2,669,679

 

 

 

 72,164

 

Interest expense, net

 

 

 435,826

 

 

 

 1,790,147

 

 

 

 2,225,973

 

Depreciation and amortization

 

 

 1,075,393

 

 

 

 1,204,628

 

 

 

 2,280,021

 

Income Tax

 

 

 (708,201 )

 

 

 755,253

 

 

 

 47,052

 

Stock Compensation

 

 

 927,326

 

 

 

 1,052,847

 

 

 

 1,980,173

 

Gain on sale of asset

 

 

 -

 

 

 

 (7,564,363 )

 

 

 (7,564,363 )

Change in derivative liability

 

 

 (1,770 )

 

 

 3,540

 

 

 

 1,770

 

Loss from discontinued operations

 

 

 45,511

 

 

 

 292,907

 

 

 

 338,418

 

Loss attributable to non-controlling interest

 

 

 (148,005 )

 

 

 (85,581 )

 

 

 (233,586 )

 

 

 

 (971,435 )

 

 

 119,057

 

 

 

 (852,378 )

 

Company Contact

Andrew Norstrud, Chief Financial Officer

Email: andrew.norstrud@upexi.com

Phone: (702) 332-5591

 

Investor Relations Contact

KCSA Strategic Communications

Valter Pinto or Jack Perkins

Email: Upexi@KCSA.com

Phone: (212) 896-1254

 

 
4

 

 

UPEXI, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

 

 

 

 

 

 

 

 

 

 

 

Three Month's Ended

December 31,

 

 

Six Month's Ended

December 31,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

 $ 27,086,672

 

 

 $ 4,983,557

 

 

 $ 38,643,683

 

 

 $ 8,853,667

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of Revenue

 

 

 16,773,493

 

 

 

 711,246

 

 

 

 22,289,773

 

 

 

 1,982,975

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

 

 10,313,179

 

 

 

 4,272,311

 

 

 

 16,353,910

 

 

 

 6,870,692

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales and marketing

 

 

 3,707,925

 

 

 

 1,735,194

 

 

 

 5,733,385

 

 

 

 2,735,258

 

Distribution costs

 

 

 3,575,545

 

 

 

 821,630

 

 

 

 6,063,379

 

 

 

 933,463

 

General and administrative expenses

 

 

 2,910,655

 

 

 

 3,003,919

 

 

 

 5,409,524

 

 

 

 4,586,351

 

Share-based compensation

 

 

 1,052,847

 

 

 

 852,455

 

 

 

 1,980,173

 

 

 

 1,479,293

 

Amortization of acquired intangible assets

 

 

 962,077

 

 

 

 236,001

 

 

 

 1,842,973

 

 

 

 304,835

 

Depreciation

 

 

 242,551

 

 

 

 159,073

 

 

 

 437,048

 

 

 

 246,579

 

 

 

 

 12,451,600

 

 

 

 6,808,272

 

 

 

 21,466,482

 

 

 

 10,285,779

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

 (2,138,421 )

 

 

 (2,535,960 )

 

 

 (5,112,572 )

 

 

 (3,415,086 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income (expense), net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest (expense) income, net

 

 

 (1,790,144 )

 

 

 (48,541 )

 

 

 (2,225,973 )

 

 

 (41,994 )

Change in derivative liability

 

 

 (3,540 )

 

 

 -

 

 

 

 (1,770 )

 

 

 -

 

Gain on sale of Infusionz and select assets

 

 

 7,564,363

 

 

 

 -

 

 

 

 7,564,363

 

 

 

 -

 

Gain on SBA PPP loan extinguishment

 

 

 -

 

 

 

 -

 

 

 

 -

 

 

 

 300,995

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income (expense), net

 

 

 5,770,679

 

 

 

 (48,541 )

 

 

 5,336,620

 

 

 

 259,001

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) on operations before income tax

 

 

 3,632,258

 

 

 

 (2,584,501 )

 

 

 224,048

 

 

 

 (3,156,085 )

Income tax expense

 

 

 (755,253 )

 

 

 (493,936 )

 

 

 (47,052 )

 

 

 (235,033 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) from continuing operations

 

 

 2,877,005

 

 

 

 (3,078,437 )

 

 

 176,996

 

 

 

 (3,391,118 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Loss) income from discontinued operations

 

 

 (292,907 )

 

 

 2,820,190

 

 

 

 (338,418 )

 

 

 3,967,662

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to non-controlling interest

 

 

 (85,581 )

 

 

 -

 

 

 

 (233,586 )

 

 

 -

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) attributable to Upexi, Inc.

 

 $ 2,669,679

 

 

 $ (258,247 )

 

 $ 72,164

 

 

 $ 576,544

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic income (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) per share from continuing operations

 

 $ 0.16

 

 

 $ (0.32 )

 

 $ 0.01

 

 

 $ (0.22 )

(Loss) income per share from discontinued operations

 

 $ (0.02 )

 

 $ 0.29

 

 

 $ (0.02 )

 

 $ 0.26

 

Total income (loss) per share

 

 $ 0.16

 

 

 $ (0.32 )

 

 $ 0.01

 

 

 $ (0.22 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted income (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) per share from continuing operations

 

 $ 0.15

 

 

 $ (0.32 )

 

 $ 0.01

 

 

 $ (0.20 )

(Loss) income per share from discontinued operations

 

 $ (0.02 )

 

 $ 0.29

 

 

 $ (0.02 )

 

 $ 0.23

 

Total income (loss) per share

 

 $ 0.15

 

 

 $ (0.32 )

 

 $ 0.01

 

 

 $ (0.20 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic weighted average shares outstanding

 

 

 17,540,427

 

 

 

 9,755,663

 

 

 

 17,126,886

 

 

 

 15,452,453

 

Fully diluted weighted average shares outstanding

 

 

 19,030,705

 

 

 

 9,755,663

 

 

 

 18,617,164

 

 

 

 17,220,564

 

 

 
5

 

 

UPEXI, INC.

CONDENSED CONSOLDIATED BALANCE SHEETS (UNAUDITED)

 

 

 

 

 

 

 

 

 

December 31,

 

 

June 30,

 

 

 

2022

 

 

2022

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Cash

 

 $ 4,508,161

 

 

 $ 7,149,806

 

Accounts receivable

 

 

 8,869,297

 

 

 

 1,137,637

 

Inventory

 

 

 6,779,997

 

 

 

 4,725,685

 

Deferred tax asset, current

 

 

 -

 

 

 

 462,070

 

Prepaid expenses and other receivables

 

 

 1,967,088

 

 

 

 840,193

 

Assets of discontinued operations, net

 

 

 -

 

 

 

 6,449,210

 

Total current assets

 

 

 22,124,543

 

 

 

 20,764,601

 

 

 

 

 

 

 

 

 

 

Property and equipment, net

 

 

 7,231,404

 

 

 

 7,343,783

 

Intangible assets, net

 

 

 18,712,409

 

 

 

 10,641,382

 

Goodwill

 

 

 15,342,089

 

 

 

 5,887,393

 

Deferred tax asset

 

 

 2,479,918

 

 

 

 2,002,759

 

Investments - Bloomios

 

 

 10,081,255

 

 

 

 -

 

Other assets

 

 

 56,703

 

 

 

 100,372

 

Right-of-use asset

 

 

 608,488

 

 

 

 926,570

 

Total other assets

 

 

 54,512,266

 

 

 

 26,902,259

 

 

 

 

 

 

 

 

 

 

Total assets

 

 $ 76,636,809

 

 

 $ 47,666,860

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

Accounts payable

 

 $ 4,162,121

 

 

 $ 2,018,541

 

Accrued compensation

 

 

 718,764

 

 

 

 531,259

 

Deferred revenue

 

 

 31,724

 

 

 

 105,848

 

Accrued liabilities

 

 

 3,898,318

 

 

 

 955,327

 

Acquisition payable

 

 

 3,978,523

 

 

 

 -

 

Current portion of notes payable

 

 

 2,117,683

 

 

 

 5,424,752

 

Current portion of operating lease payable

 

 

 187,777

 

 

 

 267,029

 

Total current liabilities

 

 

 15,094,910

 

 

 

 9,302,756

 

 

 

 

 

 

 

 

 

 

Operating lease payable, net of current portion

 

 

 375,552

 

 

 

 700,411

 

Notes payable, net of current portion

 

 

 24,420,152

 

 

 

 8,876,949

 

Total long-term liabilities

 

 

 24,795,704

 

 

 

 9,577,360

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 -

 

 

 

 -

 

 

 

 

 

 

 

 

 

 

Stockholders' equity

 

 

 

 

 

 

 

 

Preferred stock, $0.001 par value, 100,000,000 shares authorized, and 500,000 and 500,000 shares issued and outstanding, respectively

 

 

 500

 

 

 

 500

 

Common stock, $0.001 par value, 100,000,000 shares authorized, and 17,960,748 and 16,713,345 shares issued and outstanding, respectively

 

 

 17,960

 

 

 

 16,713

 

Additional paid in capital

 

 

 43,105,223

 

 

 

 34,985,597

 

Accumulated deficit

 

 

 (6,198,722 )

 

 

 (6,270,886 )

Total stockholders' equity attributable to Upexi, Inc.

 

 

 36,924,961

 

 

 

 28,731,924

 

Non-controlling interest in subsidiary

 

 

 (178,766 )

 

 

 54,820

 

Total stockholders' equity

 

 

 36,746,195

 

 

 

 28,786,744

 

 

 

 

 

 

 

 

 

 

Total liabilities and stockholders' equity

 

 $ 76,636,809

 

 

 $ 47,666,860

 

 

 
6

 

 EX-101.SCH 3 upxi-20230214.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 upxi-20230214_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Entity Emerging Growth Company Document Period End Date Entity Ex Transition Period Entity Incorporation State Country Code Entity File Number Entity Tax Identification Number Entity Address Address Line 1 Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code City Area Code Local Phone Number Written Communications Soliciting Material Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Trading Symbol Security Exchange Name EX-101.CAL 5 upxi-20230214_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 6 upxi-20230214_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 7 upxi-20230214_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE GRAPHIC 8 upxi_ex991img2.jpg begin 644 upxi_ex991img2.jpg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htm IDEA: XBRL DOCUMENT v3.22.4
Cover
Feb. 14, 2023
Cover [Abstract]  
Entity Registrant Name UPEXI, INC.
Entity Central Index Key 0001775194
Document Type 8-K
Amendment Flag false
Entity Emerging Growth Company true
Document Period End Date Feb. 14, 2023
Entity Ex Transition Period false
Entity Incorporation State Country Code NV
Entity File Number 333-25526
Entity Tax Identification Number 83-3378978
Entity Address Address Line 1 17129 US Hwy 19 N
Entity Address City Or Town Clearwater
Entity Address State Or Province FL
Entity Address Postal Zip Code 33760
City Area Code 701
Local Phone Number 353-5425
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, par value $0.001
Trading Symbol UPXI
Security Exchange Name NASDAQ
XML 10 upxi_8k_htm.xml IDEA: XBRL DOCUMENT 0001775194 2023-02-14 2023-02-14 iso4217:USD shares iso4217:USD shares 0001775194 false 8-K 2023-02-14 UPEXI, INC. NV 333-25526 83-3378978 17129 US Hwy 19 N Clearwater FL 33760 701 353-5425 false false false false Common Stock, par value $0.001 UPXI NASDAQ true false EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 1 23 1 false 0 0 false 3 false false R1.htm 000001 - Document - Cover Sheet http://grvi.com/role/Cover Cover Cover 1 false false All Reports Book All Reports upxi_8k.htm upxi-20230214.xsd upxi-20230214_cal.xml upxi-20230214_def.xml upxi-20230214_lab.xml upxi-20230214_pre.xml upxi_ex991.htm http://xbrl.sec.gov/dei/2022 true true JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "upxi_8k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 23 }, "contextCount": 1, "dts": { "calculationLink": { "local": [ "upxi-20230214_cal.xml" ] }, "definitionLink": { "local": [ "upxi-20230214_def.xml" ] }, "inline": { "local": [ "upxi_8k.htm" ] }, "labelLink": { "local": [ "upxi-20230214_lab.xml" ] }, "presentationLink": { "local": [ "upxi-20230214_pre.xml" ] }, "schema": { "local": [ "upxi-20230214.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "upxi", "nsuri": "http://grvi.com/20230214", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "upxi_8k.htm", "contextRef": "From2023-02-14to2023-02-14", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://grvi.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "upxi_8k.htm", "contextRef": "From2023-02-14to2023-02-14", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://grvi.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://grvi.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://grvi.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://grvi.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line 1" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://grvi.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://grvi.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://grvi.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://grvi.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://grvi.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://grvi.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://grvi.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://grvi.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://grvi.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://grvi.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://grvi.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://grvi.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://grvi.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://grvi.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://grvi.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://grvi.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://grvi.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://grvi.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://grvi.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 17 0001477932-23-001048-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001477932-23-001048-xbrl.zip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end